English: Quality of life of heroin dependent patients
Español: Calidad de vida de pacientes con dependencia a heroína
Português: Qualidade de vida de pacientes com dependência a heroína

Andrés Felipe Tirado Otálvaro, Matilde Ligia Álvarez Gómez, Juan david Velásquez Tirado, Luz Helena Lugo, Luis Fernando Giraldo Ferrer, Ana María Suárez Bermudez, Julieth Wiedemann

Abstract


Objective. To describe the quality of life in terms of health, in the different stages of treatment of patients addict to heroin attended in a drug-dependence attention center of Medellin.

Methodology. Cross sectional epidemiological study. 40 heroin addicts in the different stages of treatment: dishabituation, social reinsertion and maintenance program with methadone were interviewed in 2009. The SF-36 instrument for the evaluation of the quality of life and the Zung’s test for depression were used. Descriptive analysis and comparisons through non parametric tests to determine differences among the groups were performed (Group 1: Hospitalized patients, in phase of dishabituation and social reinsertion, and group 2: patients in any of the stages of the methadone’s maintenance program according to the treatment’s phase). Statistical significance was assumed if p<0.05 to determine differences among groups. 

Results. 40 patients participated (19 in group 1 and 21 in group 2). It was found that the quality of life was better in the patients in group 2 with statistical significant differences for all the domains, except for the physical function and mental health, which from the beginning had higher scores than the 75th percentile. 

Conclusion. Quality of life is better in patients who have longer time in the maintenance program with methadone.

Key words: heroin dependence; quality of life; methadone.


How to cite this article:  Tirado AF, Álvarez M, Velásquez JD, Lugo LE, Giraldo LF, Suarez AM, et al. Calidad de vida de pacientes con dependencia a heroína de un centro de atención de drogodependencias de Medellín (Colombia).Invest Educ Enferm. 2012;30(1): 35-43.


References


(1) Lakarra B, López M, Martínez J. Bases biológicas, psicológicas y socioculturales. En: Perez J, Valderrama J, Cervera G, Rubio G. Tratado SET de trastornos adictivos. Madrid: Médica Panamericana; 2006. p. 1-13.

(2) UNODC. Global illicit drug trends 2010. New York: United Nations Office on Drugs and Crime; 2010.

(3) Ministerio Protección Social (Colombia). Estudio Nacional de consumo de sustancias psicoactivas de Colombia, 2008. Bogotá: Ministerio Protección Social;2008.

(4) O’Connor G, McMahon G. Complications of heroin abuse. Eur J Emerg Med. 2008;15(2):104-6)

(5) White JM, Lopatko OV. Opioid maintenance: a comparative review of pharmacological strategies. Expert Opin Pharmacother. 2007;8(1):1-11.

(6) Kreek MJ, Borg L, Ducat E, Ray B. Pharmacotherapy in the treatment of addiction: methadone. J Addict Dis. 2010;29(2):200-16.

(7) Pettes T, Wood E, Guillemi S, Lai C, Montaner J, Kerr T. Methadone use among HIV-positive injection drug users in a Canadian setting. J Subst Abuse Treat. 2010;39(2):174-9.

(8) Campbell KM, Deck Krupski A. Impact of substance abuse treatment on arrests among opiate users in Washington state. Am J Addict. 2007;16(6):510-20.

(9) Salamina G, Diecidue R, Vigna-Taglianti F, Jarre P, Schifano P, Bargagli AM, et al. Effectiveness of therapies for heroin addiction in retaining patients in treatment: results from the VEdeTTE study. Subst Use Misuse. 2010;45(12):2076-92.

(10) Xiao L, Wu Z, Luo W, Wei X. Quality of life of outpatients in methadone maintenance treatment clinics. J Acquir Immune Defic Syndr. 2010;53 Suppl 1:S116-20.

(11) Deng CF, Ma X, Zhou H, Liu QL, Yang Y, Song Z, et al. Quality of life of heroin dependent patients with methadone maintenance therapy. Sichuan Da Xue Xue Bao Yi Xue Ban. 2009;40(3):539-43.

(12) Astals M, Domingo-Salvany A, Buenaventura CC, Tato J, Vázquez JM, Martín-Santos R, et al. Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment. Subst Use Misuse. 2008;43(5):612-32.

(13) Fassino S, Daga GA, Delsedime N, Rogna L, Boggio S. Quality of life and personality disorders in heroin abusers. Drug Alcohol Depend. 2004;76(1):73-80.

(14) Ngo HT, Tait RJ, Hulse GK. Hospital psychiatric comorbidity and its role in heroin dependence treatment outcomes using naltrexone implant or methadone maintenance. J Psychopharmacol. 2010;25(6):774-82.

(15) Risser J, Cates A, Rehman H, Risser W. Gender differences in social support and depression among injection drug users in Houston, Texas. Am J Drug Alcohol Abuse. 2010;36(1):18-24.

(16) Darke S, Mills K, Teesson M, Ross J, Williamson A, Havard A. Patterns of major depression and drug-related problems amongst heroin users across 36 months. Psychiatry Res. 2009 31;166(1):7-14.

(17) Alvarez M, Suárez A, Giraldo LF, Londoño J, Hoyos T, Bedoya C, et al. Características de las personas adictas a la heroína en tratamiento en ese carisma de enero de 2003 a junio de 2008. SMAD. 2009;5(1): 1-17.

(18) Lugo LH, García HI, Gómez C. Confiabilidad del cuestionario de calidad de vida SF36 en Medellín, Colombia. Rev Fac Nac Salud Pública. 2006;4(2):37-50.

(19) Ware JE, Sherbourne CD. TheMOS36-item shortform health survey (SF-36). Med Care. 1992;30:473–83.

(20) Zung WW. Escala de depresion de zung [Internet].Buenos Aires: Psicomag; 2008 [acceso (09 de febrero de 2009]. Disponible en: http://www.depresion.psicomag.com/esc_zung.php

(21) WHO. Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. Geneva:World Health Organization; 2009.

(22) Astals M, Domingo-Salvany A, Buenaventura CC, Tato J, Vazquez JM, Martín-Santos R, et al. Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment. Subst Use Misuse. 2008;43(5):612-32.

(23) Holt T, Ritter A, Swan A, Pahoki S. The Australian treatment outcome study (ATOS): heroin baseline data report. Victoria: Turning Point Alcohol and Drug Centre; 2002.

(24) Sanchez-Niubó A, Fortiana J, Barrio G. Problematic heroin use incidence trends in Spain. Adicction. 2009;104(2):248-55.

(25) Castaño A. Consumo de heroína en Colombia. Adicciones. 2002;14(1):87-90.

(26) Iraurgi I, Póo M, Márkes I. Valoración del índice de salud SF-36 aplicado a ususarios de programas de metadona: valores de referencia para la comunidad Vasca. Rev Esp Salud Publica. 2004;78(5):609-21.

(27) Ryan CF, White J. Health status at entry to methadone maintenance treatment using the SF-36 health survey questionnaire. Addiction.1996;91(1):39-45.

(28) Torrens M, San L, Martinez A, Castillo C, Domingo-Salvany A, Alonso J. Use of Nottingham Health Profile for measuring health status of patients in methadone maintenance treatment. Addiction. 1997;92(6): 707-16.

(29) Alonso J, Prieto L, Antó JM. The Spanish version of the Nottingham Health Profile: a review of adaptation and instrument. characteristics. Qual Life Res.1994;3:385-93.

(30) Zapata M. 9 dominios para la recuperación de la enfermedad por alcohol y drogas. Medellín:CARISMA; 2007.

(31) Richter D, Eikelmann B, Berger K. Use of the SF-36 in the evaluation of a drug detoxification program. Qual Life Res. 2004;13:907-14.

(32) Guzmán-Facundo FR, Ramos-Luna S, Alonso-Castillo MM, Esparza-Almanza SE, López-García KS, Ibarra-González C. Depression and psychoactive substances consumption in Mexican college undergraduates. Invest Educ Enferm. 2011;29(3):442-50.


Abstract : 331 Resumen : 55 Resumo : 42 PDF (Español (España)) : 124 PDF (Español) : 135 PDF (Português (Brasil)) : 66 HTML (Español) : 126

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


Esta publicación hace parte del Sistema de Revistas de la Universidad de Antioquia
¿Quieres aprender a usar el Open Journal system? Ingresa al Curso virtual
Este sistema es administrado por el Programa Integración de Tecnologías a la Docencia
Universidad de Antioquia
Powered by Public Knowledge Project